MODERNA INC
MRNANASDAQ$201.51▲ $4.31 (+2.14%)
LiveTrack MRNA
Get earnings, price moves & breaking news on Telegram
24h▲ 2.1%
7d▲ 10.4%
14d▲ 40.2%
30d▲ 46.1%
ytd▲ 583.3%
1y▲ 695.9%
🏦Market Cap
$79.96B
Mid Cap
📈Revenue Growth (YoY)
-39.2%
Declining
📊Gross Margin
-12.6%
Thin
💵FCF Margin
-54.9%
Thin
⚖️P/S Ratio
35.1x
Expensive
Otter Score
72
Fair
MODERNA INC
MRNAAnalyst Ratings
Price
$201.51
Total
29
Raised
5
Lowered
3
Avg PT
$115.70
H / L
$245 / $25
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Rothschild & Co | Downgraded | Neutral → Sell | 2026-09-03 | — | — |
Argus Research | Upgraded | Hold → Buy | 2026-08-28 | $180.00 | −10.70% |
Wolfe Research | Upgraded | Underperform → Peer Perform | 2026-08-25 | $25.00 | −87.60% |
Barclays | Reiterated | Equal Weight | 2026-08-24 | $125.00 | −38.00% |
JP Morgan | Reiterated | Underweight | 2026-08-21 | $26.00 | −87.10% |
Goldman Sachs | Reiterated | Neutral | 2026-08-20 | $120.00 | −40.40% |
Morgan Stanley | Reiterated | Equal Weight | 2026-08-20 | $39.00 | −80.60% |
UBS | Reiterated | Neutral | 2026-08-20 | $81.00 | −59.80% |
William Blair | Upgraded | Market Perform → Outperform | 2026-08-19 | — | — |
Citigroup | Reiterated | Neutral | 2026-08-03 | $40.00 | −80.10% |
RBC Capital | Reiterated | Sector Perform | 2026-07-07 | $130.00 | −35.50% |
B of A Securities | Reiterated | Underperform | 2026-07-07 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-06-26 | $77.00 | −61.80% |
Evercore ISI Group | Reiterated | In Line | 2026-05-04 | — | — |
Leerink Partners | Reiterated | Underperform | 2025-11-21 | $15.00 | −92.60% |
Needham | Reiterated | Hold | 2025-10-20 | — | — |
HSBC | Upgraded | Hold → Buy | 2024-11-18 | $58.00 | −71.20% |
Deutsche Bank | Upgraded | Sell → Hold | 2024-08-06 | $80.00 | −60.30% |
Oppenheimer | Reiterated | Outperform | 2024-06-12 | $179.00 | −11.20% |
Canaccord Genuity | Reiterated | Hold | 2024-05-03 | $106.00 | −47.40% |
Jefferies | Reiterated | Buy | 2024-04-09 | $37.00 | −81.60% |
TD Cowen | Downgraded | Outperform → Market Perform | 2023-08-04 | — | — |
Guggenheim | Reiterated | Neutral | 2023-04-26 | — | — |
SVB Leerink | Downgraded | Market Perform → Underperform | 2023-02-24 | — | — |
Cowen & Co. | Reiterated | Market Perform | 2023-01-25 | $200.00 | −0.70% |
Chardan Capital | Reiterated | Neutral | 2023-01-18 | $191.00 | −5.20% |
Brookline Capital | Reiterated | Buy | 2021-02-26 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2021-02-01 | $145.00 | −28.00% |
BMO Capital | Reiterated | Outperform | 2020-11-25 | — | — |
Institution
Rothschild & Co
Downgraded · Neutral → Sell · 2026-09-03
—
—
Argus Research
Upgraded · Hold → Buy · 2026-08-28
$180.00
−10.70%
Wolfe Research
Upgraded · Underperform → Peer Perform · 2026-08-25
$25.00
−87.60%
Barclays
Reiterated · Equal Weight · 2026-08-24
$125.00
−38.00%
JP Morgan
Reiterated · Underweight · 2026-08-21
$26.00
−87.10%
Goldman Sachs
Reiterated · Neutral · 2026-08-20
$120.00
−40.40%
Morgan Stanley
Reiterated · Equal Weight · 2026-08-20
$39.00
−80.60%
UBS
Reiterated · Neutral · 2026-08-20
$81.00
−59.80%
William Blair
Upgraded · Market Perform → Outperform · 2026-08-19
—
—
Citigroup
Reiterated · Neutral · 2026-08-03
$40.00
−80.10%
RBC Capital
Reiterated · Sector Perform · 2026-07-07
$130.00
−35.50%
B of A Securities
Reiterated · Underperform · 2026-07-07
—
—
Piper Sandler
Reiterated · Overweight · 2026-06-26
$77.00
−61.80%
Evercore ISI Group
Reiterated · In Line · 2026-05-04
—
—
Leerink Partners
Reiterated · Underperform · 2025-11-21
$15.00
−92.60%
Needham
Reiterated · Hold · 2025-10-20
—
—
HSBC
Upgraded · Hold → Buy · 2024-11-18
$58.00
−71.20%
Deutsche Bank
Upgraded · Sell → Hold · 2024-08-06
$80.00
−60.30%
Oppenheimer
Reiterated · Outperform · 2024-06-12
$179.00
−11.20%
Canaccord Genuity
Reiterated · Hold · 2024-05-03
$106.00
−47.40%
Jefferies
Reiterated · Buy · 2024-04-09
$37.00
−81.60%
TD Cowen
Downgraded · Outperform → Market Perform · 2023-08-04
—
—
Guggenheim
Reiterated · Neutral · 2023-04-26
—
—
SVB Leerink
Downgraded · Market Perform → Underperform · 2023-02-24
—
—
Cowen & Co.
Reiterated · Market Perform · 2023-01-25
$200.00
−0.70%
Chardan Capital
Reiterated · Neutral · 2023-01-18
$191.00
−5.20%
Brookline Capital
Reiterated · Buy · 2021-02-26
—
—
Wells Fargo
Reiterated · Equal Weight · 2021-02-01
$145.00
−28.00%
BMO Capital
Reiterated · Outperform · 2020-11-25
—
—
One row per institution · price target from the firm's latest published target